Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Regulus Therapeutics Inc (RGLS) Earns Buy Rating from Analysts at Chardan Capital

 

Regulus Therapeutics Inc (RGLS) Earns Buy Rating from Analysts at Chardan Capital

2016-04-14 08:07:13| Biotech - Topix.net

The brokerage set a "buy" rating and a $15.00 price target on the biopharmaceutical company's stock. Chardan Capital's target price suggests a potential upside of 91.08% from the company's previous close.

Tags: buy rating capital analysts

Category:Biotechnology and Pharmaceuticals

Latest from this category	All news
»	01.07 Mortgage rates hitting affordability - Nationwide 01.07 Hurricane Beryl Graphics 01.07 Hurricane Beryl Public Advisory Number 10A 01.07 Summary for Hurricane Beryl (AT2/AL022024) 01.07 Tropical Storm Chris Graphics 01.07 Tropical Storm Chris Public Advisory Number 2A 01.07 Atlantic Tropical Weather Outlook 01.07 Eastern North Pacific Tropical Weather Outlook More »